MiR-362-5p is a direct inhibitor of SUZ12. Knockdown of SUZ12 increased the sensitivity to cisplatin and decreased the levels of the NF-κB/p65 protein, as well as enhanced cisplatin-induced apoptosis in GC cells [115]. This evidence concerns the gene SUZ12 and gastric cancer.